As a result of the apparent hysteresis caused by ion migration, halide perovskites (HPs) are used as the active layer of resistive devices. Here, polyethylene glycol (PEG) is used to form an organic network in the CsBiBr precursor solution to influence the nucleation growth rate of the substrate and, thus, control the perovskite surface morphology, crystallization process, and halide ion migration activation energy. Furthermore, the organic network consisting of non-conducting polymer PEG rests on the boundaries between perovskite crystals to cross-link perovskite particles. As a result, the particle size of perovskite increased from 64.6 to 76.2 nm as the nucleation rate of perovskite gradually decreased with the increase of the PEG concentration and the activation energy of the ion increases from 0.15 to 0.25 eV. Meanwhile, as the concentration of PEG increases, the switching ratio and cycle stability of the devices is improved.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.jpclett.3c00991 | DOI Listing |
Biosens Bioelectron
January 2025
Beijing Institute of Technology School of Chemistry and Chemical Engineering, China. Electronic address:
Photonic crystal-based aptasensors for viral proteins detection offer the advantage of producing visible readouts. However, they usually suffer from limited sensitivity and high non-specific background noise. A significant contributing factor to these issues is the use of fixed-conformation aptamers in these sensors.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Division of Intramural Research, National Institute on Minority Health and Health Disparities, Bethesda, Maryland.
Importance: Cigarette companies have been introducing synthetic cooling agent menthol-mimicking cigarettes into the US marketplace as menthol cigarette bans are implemented. These cigarettes may reduce the public health benefits of menthol cigarette bans.
Objective: To examine the epidemiology of the use of synthetic cooling agent menthol-mimicking cigarettes among adults in the US.
Endocrinol Metab (Seoul)
January 2025
Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Background: Antithyroid drug (ATD) treatment is the preferred initial treatment for Graves' disease (GD) in South Korea, despite higher treatment failure rates than radioactive iodine (RAI) therapy or thyroidectomy. This study aimed to evaluate the incidence of treatment failure associated with the primary modalities for GD treatment in real-world practice.
Methods: We included 452,001 patients diagnosed with GD between 2004 and 2020 from the Korean National Health Insurance Service-National Health Information Database.
Endocrinol Metab (Seoul)
January 2025
Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Background: Achieving optimal glucose control is essential in the management of type 2 diabetes (T2D). This study aimed to evaluate the effectiveness and safety of oral quadruple combination therapy for the treatment of T2D.
Methods: This meta-analysis reviewed original research on oral quadruple combination therapy for T2D, including both experimental and observational studies with a minimum duration of 12 weeks.
Nanotechnology
January 2025
Department of Physics, Shanghai Jiao Tong University, 800 Dong Chuan Road, Minhang Area, Shanghai 200240, Shanghai, 200240, CHINA.
Both stability and multi-level switching are crucial performance aspects for resistive random-access memory (RRAM), each playing a significant role in improving overall device performance. In this study, we successfully integrate these two features into a single RRAM configuration by embedding Ag-nanoparticles (Ag-NPs) into the TiN/Ta2O5/ITO structure. The device exhibits substantially lower switching voltages, a larger switching ratio, and multi-level switching phenomena compared to many other nanoparticle-embedded devices.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!